The new device, a simplified CPAP machine with ventilation designed for use on infants, was created to help small, rural hospitals in developing countries where newborn resuscitation equipment often isn’t available. It offers the same technology used in U.S. hospitals but at a fraction of the cost.
![When the FDA approves the device, which is anticipated in fall 2018, it could potentially save more than 80,000 babies each year who suffer from breathing issues like apnea, asphyxia, infection and immature lungs.](https://brightspotcdn.byu.edu/dims4/default/c9365a0/2147483647/strip/true/crop/1200x798+0+0/resize/840x559!/quality/90/?url=https%3A%2F%2Fbrigham-young-brightspot-us-east-2.s3.us-east-2.amazonaws.com%2F7e%2F4e%2Fd22aed4b4e999c105b078cd243a0%2F1390-1814821.jpg)
_
Writer: Jordan Christiansen